158 related articles for article (PubMed ID: 15736658)
1. A fresh look at an old vaccine: does BCG have a role in 21st century Canada?
Dawar M; Clark M; Deeks SL; Walop W; Ahmadipour N
Int J Circumpolar Health; 2004; 63 Suppl 2():230-6. PubMed ID: 15736658
[TBL] [Abstract][Full Text] [Related]
2. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A
Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565
[TBL] [Abstract][Full Text] [Related]
3. The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.
Clark M; Cameron DW
BMC Pediatr; 2006 Mar; 6():5. PubMed ID: 16515694
[TBL] [Abstract][Full Text] [Related]
4. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada.
Cook VJ; Hernández-Garduño E; Kunimoto D; Hershfield ES; Fanning EA; Hoeppner VH; Elwood RK; FitzGerald JM;
Can Respir J; 2005 Apr; 12(3):134-8. PubMed ID: 15875064
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
6. BCG vaccination among Canadian Indians and Inuit: the epidemiological bases for policy decision.
Young TK
Can J Public Health; 1985; 76(2):124-9. PubMed ID: 4005772
[TBL] [Abstract][Full Text] [Related]
7. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015.
Wansaula Z; Wortham JM; Mindra G; Haddad MB; Salinas JL; Ashkin D; Morris SB; Grant GB; Ghosh S; Langer AJ
Emerg Infect Dis; 2019 Mar; 25(3):451-456. PubMed ID: 30789145
[TBL] [Abstract][Full Text] [Related]
11. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
12. Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021.
Jackson S; Kabir Z; Comiskey C
Vaccine; 2024 Mar; 42(8):2099-2105. PubMed ID: 38423810
[TBL] [Abstract][Full Text] [Related]
13. Disseminated bacille Calmette-Guérin infection: three recent Canadian cases. IMPACT. Immunization Monitoring Program, Active.
Scheifele D; Law B; Jadavji T
Can Commun Dis Rep; 1998 May; 24(9):69-72; discussion 73-5. PubMed ID: 9611413
[No Abstract] [Full Text] [Related]
14. Effectiveness of the Bacillus Calmette-Guerin vaccine in an Indonesian population with D543N NRAMP1 polymorphism.
Putera I; Pakasi TA; Syahmar I; Bramantyo AA; Karyadi E; Melani A; Sahiratmadja E
J Infect Dev Ctries; 2015 Jan; 9(1):42-7. PubMed ID: 25596570
[TBL] [Abstract][Full Text] [Related]
15. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
Moliva JI; Turner J; Torrelles JB
Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis infection in an Aboriginal (First Nations) population of Canada.
Smeja C; Brassard P
Int J Tuberc Lung Dis; 2000 Oct; 4(10):925-30. PubMed ID: 11055759
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in aboriginal Canadians.
Hoeppner VH; Marciniuk DD
Can Respir J; 2000; 7(2):141-6. PubMed ID: 10859400
[TBL] [Abstract][Full Text] [Related]
18. Bacille Calmette-Guérin vaccine-related disease in HIV-infected children: a systematic review.
Azzopardi P; Bennett CM; Graham SM; Duke T
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1331-44. PubMed ID: 19861003
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
Nieuwenhuizen NE; Kaufmann SHE
Front Immunol; 2018; 9():121. PubMed ID: 29459859
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
